[1] HAQUE N,BARI M S,HOSSAIN M A,et al.An overview of brucellosis[J].Mymensingh Medical Journal,2011,20(4):742-747. [2] FRANCO M P,MULDER M,GILMAN R H,et al.Human brucellosis[J].The Lancet Infectious Diseases,2007,7(12):775-786. [3] ROUSHAN M R H,EBRAHIMPOUR S. Human brucellosis:An overview[J].Caspian Journal of Internal Medicine,2015,6(1):46-47. [4] DEAN A S,CRUMP L,GRETER H,et al.Global burden of human brucellosis:A systematic review of disease frequency[J].PLoS Neglected Tropical Diseases,2012,6(10):e1865. [5] YANG H X,ZHANG S W,WANG T J,et al.Epidemiological characteristics and spatiotemporal trend analysis of human brucellosis in China,1950-2018[J].International Journal of Environmental Research and Public Health,2020,17(7):2382. [6] 韩文东,瞿涤.布鲁菌及其疫苗的相关研究[J].中国比较医学杂志,2020,30(2):114-120. [7] CARVALHO T F,HADDAD J P A,PAIXÃO T A,et al. Meta-analysis and advancement of brucellosis vaccinology[J].PLoS One,2016,11(11):e0166582. [8] LALSIAMTHARA J,LEE J H.Development and trial of vaccines against Brucella[J].Journal of Veterinary Science,2017,18(Suppl 1):281-290. [9] DONG Y,HUI Y M,ZAI X D,et al.Comparative genomic analysis of Brucella abortus vaccine strain 104M reveals a set of candidate genes associated with its virulence attenuation[J].Virulence,2015,6(8):745-754. [10] TADEPALLI G,SINGH A K,BALAKRISHNA K,et al.Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail(rOmp19+rP39)against B. abortus 544 and B. melitensis 16M infection in murine model[J].Journal of Molecular Immunology,2016,71:34-41. [11] JEZI F M,RAZAVI S,MIRNEJAD R,et al.Immunogenic and protective antigens of Brucella as vaccine candidates[J].Comparative Immunology,Microbiology and Infectious Diseases,2019,65:29-36. [12] ABKAR M,LOTFI A S,AMANI J,et al.Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis:Influence of nanoparticulation versus traditional immunization[J].Veterinary Research Communications,2015,39(4):217-228. [13] 郭凤羽,殷瑛,宰晓东,等.布鲁菌外膜蛋白Omp19突变体的构建及免疫原性研究[J].生物技术通讯,2019,30(5):589-596. [14] ZAI X D,YANG Q L,LIU K,et al.A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M[J].BMC Genomics,2017,18(1):402. [15] GHEIBI A,KHANAHMAD H,KASHFI K,et al.Development of new generation of vaccines for Brucella abortus[J].Heliyon,2018,4(12):e01079. [16] CORIA L M,RISSO G S,GUAIMAS F F,et al.Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier[J].Journal of Controlled Release,2019,293:158-171. |